[go: up one dir, main page]

CA2152780A1 - Therapie de remplacement hormonal par voie transdermique - Google Patents

Therapie de remplacement hormonal par voie transdermique

Info

Publication number
CA2152780A1
CA2152780A1 CA002152780A CA2152780A CA2152780A1 CA 2152780 A1 CA2152780 A1 CA 2152780A1 CA 002152780 A CA002152780 A CA 002152780A CA 2152780 A CA2152780 A CA 2152780A CA 2152780 A1 CA2152780 A1 CA 2152780A1
Authority
CA
Canada
Prior art keywords
day
progestin
dominant
estrogen
phase comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002152780A
Other languages
English (en)
Inventor
Robert F. Casper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jencap Research Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2152780A1 publication Critical patent/CA2152780A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002152780A 1992-12-28 1993-12-24 Therapie de remplacement hormonal par voie transdermique Abandoned CA2152780A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99682092A 1992-12-28 1992-12-28
US07/996,820 1992-12-28

Publications (1)

Publication Number Publication Date
CA2152780A1 true CA2152780A1 (fr) 1994-07-07

Family

ID=25543344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002152780A Abandoned CA2152780A1 (fr) 1992-12-28 1993-12-24 Therapie de remplacement hormonal par voie transdermique

Country Status (8)

Country Link
EP (1) EP0675720A1 (fr)
CN (1) CN1097987A (fr)
CA (1) CA2152780A1 (fr)
IL (1) IL108183A0 (fr)
MX (1) MXPA94000108A (fr)
SI (1) SI9300687A (fr)
WO (1) WO1994014450A1 (fr)
ZA (1) ZA939686B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855920A (en) * 1996-12-13 1999-01-05 Chein; Edmund Y. M. Total hormone replacement therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
AU630334B2 (en) * 1987-09-24 1992-10-29 Jencap Research Ltd. Hormone preparations for hormone replacement therapy and contraceptive method

Also Published As

Publication number Publication date
WO1994014450A1 (fr) 1994-07-07
MXPA94000108A (es) 2004-08-20
CN1097987A (zh) 1995-02-01
SI9300687A (en) 1994-09-30
IL108183A0 (en) 1994-04-12
ZA939686B (en) 1994-08-29
EP0675720A1 (fr) 1995-10-11

Similar Documents

Publication Publication Date Title
US5422119A (en) Transdermal hormone replacement therapy
JP2975684B2 (ja) 経皮避妊製剤、方法及びデバイス
CA2267743C (fr) Traitement hormonal substitutif interrompu avec faible dose d'oestrogene
RU2139056C1 (ru) Гормональная заместительная терапия
US5686097A (en) Monoglyceride/lactate ester permeation enhancer for codelivery of steroids
DE69434491T3 (de) Hautpflaster enthaltend testosteron und gegebenenfalls östrogen
RU2340345C2 (ru) Схема восполнения эстрогена
US5108995A (en) Hormone preparation and method
JP3314207B2 (ja) ホルモン製剤及び方法
US20090311312A1 (en) Transdermal Hormone Delivery System: Compositions And Methods
DE60307602T2 (de) Kontinuierliche sulfatase-hemmende progestogen enthaltende hormonsubstitutions-therapie
JPH06502419A (ja) 経皮避妊製剤、方法及びデバイス
EP0744944A1 (fr) Systemes therapeutiques transdermiques contenant des steroides sexuels
MXPA01012769A (es) Administracion de esteroides androgenicos no orales para mujeres.
BG65849B1 (bg) Дроспиренон за хормонзаместваща терапия
CA2152780A1 (fr) Therapie de remplacement hormonal par voie transdermique
DE102004023984A1 (de) Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
JPH07504672A (ja) 更年期骨粗鬆症の処置に対するエストリオールの使用
AU2005201151B2 (en) Low dose estrogen interrupted hormone replacement therapy
Watkinson The pharmacokinetics of drug delivery systems in hormone replacement therapy
Mishell Jr The transdermal contraceptive system: Efficacy and safety
Diczfalusy Patch up the Menopause
SK25299A3 (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued